Kinaxis (TSE:KXS) Price Target Raised to C$200.00

Kinaxis (TSE:KXSGet Free Report) had its price target upped by stock analysts at BMO Capital Markets from C$195.00 to C$200.00 in a research note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. BMO Capital Markets’ target price would indicate a potential upside of 14.84% from the company’s previous close.

A number of other research analysts also recently issued reports on KXS. Royal Bank Of Canada lifted their price objective on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a research report on Friday, May 8th. Stifel Nicolaus lowered their target price on shares of Kinaxis from C$245.00 to C$200.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. National Bank Financial lifted their price target on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Canadian Imperial Bank of Commerce upped their price target on Kinaxis from C$173.00 to C$205.00 in a research report on Friday, June 5th. Seven analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of C$203.12.

View Our Latest Stock Report on Kinaxis

Kinaxis Stock Up 2.5%

Shares of KXS traded up C$4.19 during trading hours on Friday, hitting C$174.15. The company had a trading volume of 85,293 shares, compared to its average volume of 122,823. The company has a current ratio of 1.72, a quick ratio of 2.29 and a debt-to-equity ratio of 12.15. The company has a market capitalization of C$4.76 billion, a PE ratio of 59.23, a price-to-earnings-growth ratio of 3.60 and a beta of 0.76. Kinaxis has a one year low of C$117.22 and a one year high of C$204.85. The company’s fifty day moving average price is C$157.76 and its two-hundred day moving average price is C$144.97.

Kinaxis (TSE:KXSGet Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C$1.08 earnings per share for the quarter. The company had revenue of C$230.64 million for the quarter. Kinaxis had a return on equity of 19.72% and a net margin of 14.48%. As a group, equities analysts forecast that Kinaxis will post 4.2526231 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Conrad John Mandala sold 30,000 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of C$148.10, for a total transaction of C$4,443,000.00. Following the transaction, the insider owned 820 shares in the company, valued at C$121,442. This represents a 97.34% decrease in their ownership of the stock. Also, Director Robert G. Courteau sold 5,010 shares of the stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the completion of the transaction, the director directly owned 32,945 shares of the company’s stock, valued at C$4,987,543.55. The trade was a 13.20% decrease in their ownership of the stock. In the last 90 days, insiders have sold 35,934 shares of company stock worth $5,328,181. Corporate insiders own 1.20% of the company’s stock.

About Kinaxis

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.